Gapping up
In reaction to strong earnings/guidance: NOK +6.7% (also appoints Rajeev Suri as President and CEO and announces new strategy, program to optimize capital structure, and leadership team), AIXG +6.7%, AMKR +6.1%, BWLD +5.7%, MGM +5.3% (light volume), STO +4.8%, KLIC +4.8%, ORAN +4.5%, CMI +3.7%, HW +3.1%, S +3%, STM +2.7%, DB +2.5%, RUTH +2.1%, (light volume), N +2%, HIG +1.8%, MRK +1.1%, AMP +1.4%, (authorizes additional $2.5 bln for the repurchase of shares of its common stock through April 28, 2016; increases quarterly dividend by 12% to $0.58 per share from $0.52 per share), BP +1.3%, SAVE +1.1%, BSX +1%, SCOR +0.7%, (also ComScore and Yahoo partner to expand global access to ad measurement), RRC+0.6%, FRX +0.6%, PRE +0.5%, PCAR +0.3%.
M&A news: ORB +5.4% and ATK +1.6% (Orbital Sciences and Allian Techsystems' Aerospace and Defense Groups to combine in $5 billion merger-of-equals to create 'Orbital ATK', a New Global Aerospace and Defense Systems Company), CBST +5.5% (SHPG for CBST speculation arising from FT Alphaville story), AZN +1.6% (Pfizer may have to spend EUR 70 bln on AstraZeneca (AZN), analysts say, according to reports), ARCP +1% (American Realty Capital says it is not currently in discussions with NorthStar).
Select financial related names showing strength: BSBR +12.5% and SAN +0.9% (Banco Santander announced an offer to acquire 25% of its Brazilian subsidiary, Banco Santander Brasil ), UBS +2.1%, HSBC +1.6%, CS +1.6%.
China ADRs trading higher: CHU +6.5%, CHL +3.8%.... China internet related names: DANG +3.3%, YOKU +2.1%, QIHU +2%, TEDU +1.9%, BIDU +1.1%
Other news: FOLD +46.7% (announces positive 12- and 24-month data from Phase 3 Fabry monotherapy study 011; migalastat demonstrated statistically significant (p=0.013) and durable substrate reductions on 12-month pre-specified primary analysis in Fabry patients with amenable mutations), NVAX +9.1% (announces positive top-line data from dose-confirmatory Phase 2 Clinical Trial of its RSV vaccine candidate in women of childbearing age), CETV +8.7% (still checking), BBRY +3.2%/ALU +2.6%/ERIC +1.8% (following NOK results), Z +1.9% (Tiger Global discloses 9.5% stake in 13G), NVS +0.9% (CHMP recommends EU label expansion of co's Gilenya and data at AAN confirm efficacy on pre-treated MS patients), CYTK +0.9% (announces additional results from BENEFIT-ALS; First Clinical Trial in patients with ALS to show a significant reduction in decline of slow vital capacity), MILL +0.9% (Provides Operational Update; Successfully tests the Tyonek G zone in its Sword No. 1 well at approximately 290 BOPD), TKR +0.4% (acquires Schulz Group, based in New Haven, Conn), AWAY +0.4% (positive MadMoney mention), SGMS +0.3% (signs primary instant games contract with Washington State Lottery), SODA +0.3% (SodaStream appointed Yoram Evan as Chief Commercial Officer), XOM +0.4% (starts production ahead of schedule at PNG LNG Project; Project remains on target for first LNG cargo in the coming weeks).
Analyst comments: HPQ +1.2% (upgraded to Outperform from Sector Perform at Pacific Crest), OXGN +6.7% (initiated with a Buy at H.C. Wainwright), BWP +5.6% (upgraded to Market Perform at Raymond James; upgraded to Equal-Weight from Underweight at Morgan Stanley), ISRG +1.1% (upgraded to Neutral from Underperform at Sterne Agee), IRBT +1% (upgraded to Neutral from Underweight at JP Morgan ), RCL +0.8% (initiated with a Buy at Berenberg)
M&A news: ORB +5.4% and ATK +1.6% (Orbital Sciences and Allian Techsystems' Aerospace and Defense Groups to combine in $5 billion merger-of-equals to create 'Orbital ATK', a New Global Aerospace and Defense Systems Company), CBST +5.5% (SHPG for CBST speculation arising from FT Alphaville story), AZN +1.6% (Pfizer may have to spend EUR 70 bln on AstraZeneca (AZN), analysts say, according to reports), ARCP +1% (American Realty Capital says it is not currently in discussions with NorthStar).
Select financial related names showing strength: BSBR +12.5% and SAN +0.9% (Banco Santander announced an offer to acquire 25% of its Brazilian subsidiary, Banco Santander Brasil ), UBS +2.1%, HSBC +1.6%, CS +1.6%.
China ADRs trading higher: CHU +6.5%, CHL +3.8%.... China internet related names: DANG +3.3%, YOKU +2.1%, QIHU +2%, TEDU +1.9%, BIDU +1.1%
Other news: FOLD +46.7% (announces positive 12- and 24-month data from Phase 3 Fabry monotherapy study 011; migalastat demonstrated statistically significant (p=0.013) and durable substrate reductions on 12-month pre-specified primary analysis in Fabry patients with amenable mutations), NVAX +9.1% (announces positive top-line data from dose-confirmatory Phase 2 Clinical Trial of its RSV vaccine candidate in women of childbearing age), CETV +8.7% (still checking), BBRY +3.2%/ALU +2.6%/ERIC +1.8% (following NOK results), Z +1.9% (Tiger Global discloses 9.5% stake in 13G), NVS +0.9% (CHMP recommends EU label expansion of co's Gilenya and data at AAN confirm efficacy on pre-treated MS patients), CYTK +0.9% (announces additional results from BENEFIT-ALS; First Clinical Trial in patients with ALS to show a significant reduction in decline of slow vital capacity), MILL +0.9% (Provides Operational Update; Successfully tests the Tyonek G zone in its Sword No. 1 well at approximately 290 BOPD), TKR +0.4% (acquires Schulz Group, based in New Haven, Conn), AWAY +0.4% (positive MadMoney mention), SGMS +0.3% (signs primary instant games contract with Washington State Lottery), SODA +0.3% (SodaStream appointed Yoram Evan as Chief Commercial Officer), XOM +0.4% (starts production ahead of schedule at PNG LNG Project; Project remains on target for first LNG cargo in the coming weeks).
Analyst comments: HPQ +1.2% (upgraded to Outperform from Sector Perform at Pacific Crest), OXGN +6.7% (initiated with a Buy at H.C. Wainwright), BWP +5.6% (upgraded to Market Perform at Raymond James; upgraded to Equal-Weight from Underweight at Morgan Stanley), ISRG +1.1% (upgraded to Neutral from Underperform at Sterne Agee), IRBT +1% (upgraded to Neutral from Underweight at JP Morgan ), RCL +0.8% (initiated with a Buy at Berenberg)